HCV Drugs May Reactivate HBV, FDA Warns HCV Drugs May Reactivate HBV, FDA Warns

A boxed warning for nine direct-acting antiviral drugs for HCV advises clinicians to screen for current or prior HVB infections.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news